Aspects of the invention described herein are directed to methods of treating, inhibiting, ameliorating, and / or eliminating viruses or cancer cells in a subject using genetically engineered human T-cells having receptors for the molecules presented by the virus or cancer cells Wherein the genetically engineered T cells are isolated using a two step MTX selection using increasing concentrations of MTX.
展开▼
